Moderna (MRNA) has had the lowest return since January 1, 2022 by a large-cap US stock, returning -88.8%.
Moderna (MRNA) has had the lowest return since January 1, 2022 by a large-cap US stock, returning -88.8%.
Large-cap stocks are treated as having a market cap of $10B+.